TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $594,187 | -41.2% | 71,075 | +5.8% | 0.00% | -75.0% |
| Q1 2023 | $1,010,372 | +2.7% | 67,179 | -19.2% | 0.00% | 0.0% |
| Q4 2022 | $983,463 | +42.9% | 83,133 | -28.4% | 0.00% | +33.3% |
| Q3 2022 | $688,000 | +173.0% | 116,138 | +774.6% | 0.00% | +200.0% |
| Q4 2021 | $252,000 | -65.2% | 13,279 | -82.0% | 0.00% | -94.7% |
| Q1 2020 | $724,000 | +134.3% | 73,590 | +106.2% | 0.02% | +533.3% |
| Q2 2019 | $309,000 | +47.1% | 35,696 | +36.9% | 0.00% | +50.0% |
| Q1 2019 | $210,000 | +12.3% | 26,075 | +83.6% | 0.00% | 0.0% |
| Q2 2018 | $187,000 | -7.4% | 14,200 | -0.1% | 0.00% | -33.3% |
| Q1 2018 | $202,000 | +37.4% | 14,219 | -20.9% | 0.00% | 0.0% |
| Q4 2017 | $147,000 | -20.1% | 17,974 | -54.6% | 0.00% | -62.5% |
| Q4 2016 | $184,000 | -34.3% | 39,605 | +68.5% | 0.01% | -74.2% |
| Q4 2015 | $280,000 | – | 23,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |